Literature DB >> 11917519

Studies of the molecular basis for cystic fibrosis using purified reconstituted CFTR protein.

Ilana Kogan1, Mohabir Ramjeesingh, Canhui Li, Christine E Bear.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11917519     DOI: 10.1385/1-59259-187-6:143

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


× No keyword cloud information.
  10 in total

1.  Nucleotides bind to the C-terminus of ClC-5.

Authors:  Leigh Wellhauser; Hsin-Hen Kuo; Fiona L L Stratford; Mohabir Ramjeesingh; Ling-Jun Huan; Winnie Luong; Canhui Li; Charles M Deber; Christine E Bear
Journal:  Biochem J       Date:  2006-09-01       Impact factor: 3.857

2.  Specific stabilization of CFTR by phosphatidylserine.

Authors:  Ellen Hildebrandt; Netaly Khazanov; John C Kappes; Qun Dai; Hanoch Senderowitz; Ina L Urbatsch
Journal:  Biochim Biophys Acta Biomembr       Date:  2016-11-30       Impact factor: 3.747

Review 3.  Current insights into the role of PKA phosphorylation in CFTR channel activity and the pharmacological rescue of cystic fibrosis disease-causing mutants.

Authors:  Stephanie Chin; Maurita Hung; Christine E Bear
Journal:  Cell Mol Life Sci       Date:  2016-10-08       Impact factor: 9.261

4.  ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity.

Authors:  Xiaoyang Wu; Atsuko Kodama; Elaine Fuchs
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

5.  CFTR directly mediates nucleotide-regulated glutathione flux.

Authors:  Ilana Kogan; Mohabir Ramjeesingh; Canhui Li; Jackie F Kidd; Yanchun Wang; Elaine M Leslie; Susan P C Cole; Christine E Bear
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

6.  ATP-driven self-assembly of a morphogenetic protein in Bacillus subtilis.

Authors:  Kumaran S Ramamurthi; Richard Losick
Journal:  Mol Cell       Date:  2008-08-08       Impact factor: 17.970

7.  Cystic fibrosis transmembrane conductance regulator: the NBF1+R (nucleotide-binding fold 1 and regulatory domain) segment acting alone catalyses a Co2+/Mn2+/Mg2+-ATPase activity markedly inhibited by both Cd2+ and the transition-state analogue orthovanadate.

Authors:  Jean Philippe Annereau; Young Hee Ko; Peter L Pedersen
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

8.  Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner.

Authors:  Paul D W Eckford; Canhui Li; Mohabir Ramjeesingh; Christine E Bear
Journal:  J Biol Chem       Date:  2012-08-31       Impact factor: 5.157

9.  Identification of binding sites for ivacaftor on the cystic fibrosis transmembrane conductance regulator.

Authors:  Onofrio Laselva; Zafar Qureshi; Zhi-Wei Zeng; Evgeniy V Petrotchenko; Mohabir Ramjeesingh; C Michael Hamilton; Ling-Jun Huan; Christoph H Borchers; Régis Pomès; Robert Young; Christine E Bear
Journal:  iScience       Date:  2021-05-15

10.  Cholesterol Interaction Directly Enhances Intrinsic Activity of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).

Authors:  Stephanie Chin; Mohabir Ramjeesingh; Maurita Hung; June Ereño-Oreba; Hong Cui; Onofrio Laselva; Jean-Philippe Julien; Christine E Bear
Journal:  Cells       Date:  2019-07-31       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.